Injection

PACLITAXEL

Ovarian carcinoma  First-line therapy in combination with a platinum compound for the treatment of advanced metastatic carcinoma of the ovary.  Second-line therapy for the treatment of advanced metastatic carcinoma of the ovary.   Breast carcinoma  Adjuvant treatment of node-positive breast cancer administered sequentially to standard combination therapy.  Therapy after relapse within 6 months of adjuvant […]

PACLITAXEL Read More »

DOCETAXEL

Indication :  Breast cancer  Non-Small cell lung cancer  Prostate cancer  Gastric adenocarcinoma  Head and neck cancer  Ovarian cancer   Compositions : Each mL contain Docetaxel trihydrate 21.34 mg ~ Docetaxel 20 mg   Storage Condition : Do not store above 30°C. Store in the original package in order to protect from light. Keep out the

DOCETAXEL Read More »

OXALIPLATIN

Indication :  Oxaliplatin in combination with 5-Fluorouracil (5-FU) and folinic acid (FA) is indicated for: adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumor treatment of metastatic colorectal cancer   Compositions : Eeach mL contain Oxaliplatin 5 mg   Storage Condition :  Store below 30°C, in a hermetic container. 

OXALIPLATIN Read More »

DOXORUBICIN

Indication : Doxorubicin HCl is indicated for regression in disseminated neoplastic conditions such as acute leukemia, Wilms tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, lung cancer, Hodgkin’s disease and non-Hodgkin’s lymphoma, bronchogenic carcinoma, and gastric carcinoma.   Compositions : Each mL contain Doxorubicin hydrochloride 2

DOXORUBICIN Read More »

EPIRUBICIN

Indication :  Epirubicin HCl administered as a single agent has shown to produce regression in a broad spectrum of tumours including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Prelimenary findings indicate that the drug has produced some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with

EPIRUBICIN Read More »

CARBOPLATIN

Indication : Advanced ovarian carcinoma Small cell and non small cell carcinoma of the lung Squamous cell carcinoma of the head and neck Advanced transitional cell carcinoma of the bladder Significant responses have been observed when Carboplatin employed in the treatment of carcinoma of the cervix. Carboplatin is frequently used in combination with other chemotherapeutic

CARBOPLATIN Read More »

GEMCITABINE

Indication :  Non-small cell lung cancer:  Pancreatic cancer:  Bladder cancer:  Breast cancer:  Ovarian cancer:  Other therapeutic activity: Gemcitabine alone or in combination has shown activity in advanced breast and ovarian cancer.   Compositions :  Each mL contain Gemcitabine hydrochloride 43.27 mg ~ Gemcitabine 38.005 mg   Storage Condition :  Store in refrigerator (2 – 8°C).

GEMCITABINE Read More »

METHOTREXATE

Indication : Methotrexate is indicated in the treatment gestational choriocarcinoma, chorio adenoma destruens and hydatidiform mole. In acute lymphatic leukemia, Methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agent, Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone

METHOTREXATE Read More »

Need More Information?

Contact CKD OTTO Pharma now for more information about our products and services.

Scroll to Top